Kimberly Clark Professional appoints regional sales leader

Stephen Kerr will oversee workplace safety and washroom businesses

Kimberly Clark Professional, a global supplier of hygiene and safety products, has appointed Stephen Kerr as its new regional sales leader for the UK, Ireland, the Netherlands, Belgium and Luxembourg.

Kerr takes responsibility for overseeing the company’s workplace safety and washroom businesses. He will be based out of Kimberly Clark Professional UK offices at King’s Hill, Kent.

Kerr first joined the firm as a territory salesman in 1986 after graduating from the University of Stirling. In 1997, having risen to sales manager, he left to become a director of Scotland-based distributor Unico.

In 2004, he left Unico to set up his own consultancy business and run for Parliament, before rejoining Kimberly-Clark two years later to oversee key accounts and distributor accounts for the UK and Ireland business.

In 2008, Kerr was appointed European key account manager for Bunzl, one of Kimberly Clark Professional’s customers, a position he held until taking up his new role.

You may also like

Design & Build

Winners of the Cleanroom Technology 2018 Awards announced

Industry awards have been presented at this year's international conference in Birmingham
Regulatory

Overcoming CMC challenges in cell and gene therapy: part II

Certara’s Dr Hien Anh Bruno, Associate Director, Chemistry, Manufacturing and Controls (CMC), and Dr Deven Shah, CMC Lead, propose mitigation strategies to address the CMC challenges inherent in producing cell and gene therapy (CGT) drugs
Regulatory

Overcoming CMC challenges in cell and gene therapy: part I

Certara’s Dr Hien Anh Bruno, Associate Director, Chemistry, Manufacturing and Controls (CMC), and Dr Deven Shah, CMC Lead, propose mitigation strategies to address the CMC challenges inherent in producing cell and gene therapy (CGT) drugs
Regulatory

AskBio receives FDA Fast Track Designation for congestive heart failure gene therapy programme

The fast-tracking allows the development and expedition of review processes for AB-1002, a gene therapy to promote production of a constituently active form of I-1c
Manufacturing

Chemistry, manufacturing and control (CMC) as key drivers for drug discovery success

Embracing collaborative strategies not only accelerates drug development programmes but also fosters science-based milestone decisions, mitigates risks and prepares for successful market entry from the early stages of development, reports Frederick Duynslaeger, Senior CMC Writer at Ardena
Regulatory

Isospec Analytics launches biomolecular analysis technology to identify unknown molecules

The novel technology optimises the identification process of unknown molecules compared to mass analysis
Regulatory

4SC AG receives Paediatric Investigation Plan waiver for resminostat from the UK MHRA

The waiver allows the company to avoid investigating the CTCL drug in a paediatric population, as it's considered unnecessary or inappropriate for use by this patient group
Subscribe now